Publication:
Oxytocin and hypothalamo-pituitaryadrenal axis [Oksitosin ve hipotalamus-hipofiz-adrenal bez ekseni]

dc.contributor.authorYEGEN, BERRAK
dc.contributor.authorsYeǧen B.Ç.
dc.date.accessioned2022-03-15T08:23:15Z
dc.date.accessioned2026-01-11T11:11:00Z
dc.date.available2022-03-15T08:23:15Z
dc.date.issued2010-01-01
dc.description.abstractUpon exposure to different types of stressors, neuroendocrine and behavioral responses that include the activation of the hypothalamus-pituitary-adrenal (HPA) axis are given to allow the individuals to cope with stress conditions. It was proven that oxytocin, a nonapeptide released from the posterior pituitary, has behavioral and stress-attenuating effects by dampening HPA activity. On the other hand, the neuropeptide was also shown to exert anti-inflammatory effects through the modulation of immune and inflammatory processes in several experimental models of tissue injury. The findings of recent studies suggest that the anti-inflammatory effect of oxytocin depends on its role on HPA axis activity and subsequent release of cortisol. Thus, oxytocin seems to restrain the activity within the HPAaxis, which becomes overactive during many inflammatory processes.
dc.identifier.doi10.12991/201014450
dc.identifier.issn13090801
dc.identifier.urihttps://hdl.handle.net/11424/248340
dc.language.isoeng
dc.language.isotur
dc.relation.ispartofMarmara Pharmaceutical Journal
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHPA axis
dc.subjectOxidative stress
dc.subjectOxytocin
dc.subjectStress
dc.titleOxytocin and hypothalamo-pituitaryadrenal axis [Oksitosin ve hipotalamus-hipofiz-adrenal bez ekseni]
dc.typereview
dspace.entity.typePublication
oaire.citation.endPage66
oaire.citation.issue2
oaire.citation.startPage61
oaire.citation.titleMarmara Pharmaceutical Journal
oaire.citation.volume14

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
228.6 KB
Format:
Adobe Portable Document Format